Not a good buy right now at ~26.03 pre-market: price is pressing into near-term resistance with momentum cooling.
Trend is still bullish (moving averages stacked up), but short-term reward/risk is less attractive after the run-up.
Options positioning is very call-heavy (bullish), yet near-term statistical pattern signals lean slightly negative over 1W/1M.
With earnings (QDEC 2025) on 2026-02-05 pre-market, a better entry is typically on a pullback toward ~25.23 (pivot) / ~24.47 (S1) rather than chasing strength.
Earnings catalyst upcoming: QDEC 2025 results on 2026-02-05 pre-market (could unlock another leg higher if results/guide impress).
Strategic positives cited by analysts: exposure to higher-growth markets (Mexico/South America) and potential for significant shareholder capital return (JPMorgan view).
Neutral/Negative Catalysts
Near-term technical setup is less attractive: momentum is fading while price is near resistance (R1/R2 zone).
Pattern-based forward outlook provided is slightly negative (next week/month bias).
Valuation concern emerging: RBC downgrade to Sector Perform noted upside may be “harder to come by” at current valuation levels.
No supportive news flow in the last week to justify chasing a pre-market pop.
Recent trend: Mostly upward price targets and several Buys/Overweights (Citi, JPMorgan, Goldman, Deutsche), but a notable late-January downgrade from RBC to Sector Perform due to “full-ish” valuation.
Wall Street pros: growth-market exposure, strong core revenue outlook, and potential large capital return to shareholders.
Wall Street cons: valuation now viewed as less compelling by at least one major shop (RBC), implying limited near-term multiple expansion.
Influential/congress activity: No recent congress trading data available; hedge fund and insider trading trends are neutral.
Wall Street analysts forecast BBVA stock price to fall over the next 12 months. According to Wall Street analysts, the average 1-year price target for BBVA is 23 USD with a low forecast of 23 USD and a high forecast of 23 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
1 Analyst Rating
Wall Street analysts forecast BBVA stock price to fall over the next 12 months. According to Wall Street analysts, the average 1-year price target for BBVA is 23 USD with a low forecast of 23 USD and a high forecast of 23 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
1 Buy
0 Hold
0 Sell
Moderate Buy
Current: 23.200
Low
23
Averages
23
High
23
Current: 23.200
Low
23
Averages
23
High
23
Morgan Stanley
Equal Weight
downgrade
AI Analysis
2026-02-06
New
Reason
Morgan Stanley
Price Target
AI Analysis
2026-02-06
New
downgrade
Equal Weight
Reason
Morgan Stanley lowered the firm's price target on BBVA to EUR 20 from EUR 20.70 and keeps an Equal Weight rating on the shares.
RBC Capital
Outperform -> Sector Perform
downgrade
2026-01-28
Reason
RBC Capital
Price Target
2026-01-28
downgrade
Outperform -> Sector Perform
Reason
RBC Capital downgraded BBVA to Sector Perform from Outperform with a price target of EUR 19.75, up from EUR 19.25. While the bank is "best in its class across a number of metrics," further increases in the stock at current valuation levels "could be much harder to come by," the analyst tells investors in a research note. RBC views BBVA's valuation as currently "full-ish."
Unlock Full Analyst Thesis， Get the complete breakdown of rating reason for BBVA
